Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$141.52 - $156.4 $410,408 - $453,560
2,900 Added 362.5%
3,700 $569,000
Q1 2024

May 15, 2024

BUY
$145.08 - $160.46 $58,032 - $64,184
400 Added 100.0%
800 $123,000
Q4 2023

Feb 14, 2024

SELL
$132.5 - $158.45 $251,750 - $301,055
-1,900 Reduced 82.61%
400 $63,000
Q3 2023

Nov 14, 2023

BUY
$145.69 - $157.89 $101,983 - $110,522
700 Added 43.75%
2,300 $336,000
Q2 2023

Aug 14, 2023

SELL
$151.19 - $159.79 $740,831 - $782,971
-4,900 Reduced 75.38%
1,600 $245,000
Q1 2023

May 15, 2023

BUY
$147.92 - $165.37 $517,719 - $578,795
3,500 Added 116.67%
6,500 $1.01 Million
Q4 2022

Feb 14, 2023

SELL
$132.87 - $159.04 $704,211 - $842,912
-5,300 Reduced 63.86%
3,000 $462,000
Q3 2022

Nov 14, 2022

BUY
$128.6 - $149.75 $1.07 Million - $1.24 Million
8,300 New
8,300 $1.1 Million

Others Institutions Holding FBT

About FIRST TRUST NYSE ARCA BIOTECHN


  • Ticker FBT
  • Sector ETFs
  • Industry ETFs
More about FBT
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.